Biomarkers of Heart Failure: Current Status and Future Promise is the second of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. During this program, AACC President-Elect, Robert Christenson, PhD, will describe how clinicians are currently using markers such as BNP and NT-proBNP to diagnose, risk-stratify and manage heart failure patients. Dr. Christenson will also provide an update on other markers used in heart failure diagnosis and management, including mid-region proADM and Galectin-3.

Online registration for this event is now closed. If you would like to register for this event, please contact Customer Service at (800) 892-1400, Option 2.

This educational program is sponsored by AACC, who would like to thank BG Medicine for their support of this webinar and their commitment to the clinical laboratory.